Effect of prophylactic Brimonidine instillation on bleeding during Strabismus surgery in adults
ISRCTN | ISRCTN31792393 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN31792393 |
Secondary identifying numbers | 1 |
- Submission date
- 03/04/2007
- Registration date
- 13/04/2007
- Last edited
- 11/08/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Sueng-Han Han
Scientific
Scientific
Institute of Vision Research
Department of Ophthalmology
Yongdong Severance Hospital
Yonsei University College of Medicine
146-92 Dokok-dong
Kangnam-gu
Seoul
135-720
Korea, South
Phone | +82 (0)2 2019 3440 |
---|---|
samini@yumc.yonsei.ac.kr |
Study information
Study design | Randomised comparative interventional case series |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study acronym | BS |
Study objectives | Topical brimonidine administration before strabismus surgery reduced intraoperative bleeding and postoperative subconjunctival haemorrhage in adult patients. |
Ethics approval(s) | There was no Institutional Review Board (IRB) at the time of studying. The IRB of our institute was established in 2006, but this study was performed from 2004 to 2005, and our IRB does not approve already completed studies. All participants understood the procedure exactly and gave informed consent, and the Helsinki declaration and all federal laws were followed. |
Health condition(s) or problem(s) studied | Strabismus |
Intervention | Patients were instilled with either a single drop of brimonidine-purite 0.15%, phenylephrine 1% or sodium hyaluronate 0.1% 15 minutes prior to strabismus surgery. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Brimonidine, phenylephrine, sodium hyaluronate |
Primary outcome measure | Intraoperative bleeding and postoperative subconjunctival haemorrhage were graded on a scale of one to three. Intraoperative bleeding was scored during the surgery, postoperative subconjunctival haemorrhage was graded four hours after surgery. |
Secondary outcome measures | Cardiovascular complications and angle-closure glaucoma attack were reported during all follow up periods. |
Overall study start date | 10/01/2004 |
Completion date | 04/05/2007 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 90 |
Key inclusion criteria | Adult patients who underwent strabismus surgery under topical anaesthesia. |
Key exclusion criteria | Patients who had received prior ocular surgery were excluded. |
Date of first enrolment | 10/01/2004 |
Date of final enrolment | 04/05/2007 |
Locations
Countries of recruitment
- Korea, South
Study participating centre
Institute of Vision Research
Seoul
135-720
Korea, South
135-720
Korea, South
Sponsor information
Yonsei University College of Medicine (South Korea)
Hospital/treatment centre
Hospital/treatment centre
146-92 Dogok-dong
Kangnam-gu
Seoul
135-720
Korea, South
samini@yumc.yonsei.ac.kr | |
https://ror.org/01wjejq96 |
Funders
Funder type
Hospital/treatment centre
Yongdong Severance Hospital (South Korea)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | Results | 01/09/2007 | Yes | No |